key: cord-0426982-89tmea0h authors: Arif, M.; Larik, E.; Saeed, A.; Abdullah, M. title: Measuring odds of various COVID-19 infection prevention & control measures among the contacts traced during trace test and quarantine activities at district Quetta (An un-matched case control study). date: 2021-07-30 journal: nan DOI: 10.1101/2021.07.25.21261084 sha: bfb979498d5cf2feee25ec5d3801f2d51295f8e4 doc_id: 426982 cord_uid: 89tmea0h Background: The second wave of COVID-19 pandemic has started globally, right now globally 220 countries are infected and a total of 71351695 confirmed cases and 1612372 deaths due to COVID-19 has been reported so far1. As of today i.e. (16th Dec 2020) a total of 11430955 new COVID-19 confirmed cases have been reported across the south-east asia1. These cases are showing an increasing trend in all the Asian countries including Pakistan1. Across Pakistan till date 440787 new confirmed COVID-19 cases have been reported across the Pakistan showing a doubling time of 10.63 days (95% C.I 9.68- 11.8), while a total of 8832 new deaths have been reported across the Pakistan making the double time for death as 11.11 days (95% C.I 4.04-14.86) 1. Till the development and availability of a vaccine the only tools that can help prevent the spread of COVID-19 are IPC measures violating them can result in a quick spread across the population3. This study was conducted to assess the odds of various COVID-19 IPC measures among the Contacts of an index COVID-19 case traced by Provincial Disease Surveillance & Response unit Quetta. Methodology: Sample Size & Sampling technique: Using the detailed epidemiological reports of 600 COVID-19 contacts identified during the trace test and quarantine field activities form 1st October till 30th October 2020 in district Quetta, from this data a sample of 300 individuals was selected for this study using Simple random sampling technique. Study Design: Considering different exposure rates and pandemic situation an Un-matched Case control study study was conducted where Cases were defined as Every PCR positive contact (Symptomatic or asymptomatic) for any index case similarly Controls were defined as Every PCR negative contact (Symptomatic or asymptomatic) for any index case who was home quarantined for 14 days based on suspicion by PDSRU team. A set ratio of 1:2 for cases & controls respectively was used for this study. Results: The odds for various IPC measures like Knowingly and intentionally Contacted with a COVID-19 positive case, Family member of the index COVID-19 case, Knowingly and intentionally received an object handed over by a COVID-19 Positive case, Touched the same surface/surfaces after it was touched by the index case, Not doing regular Hand washing, Knowingly and intentionally did not follow the government SOPs of Social Distancing During encounter with a positive symptomatic case, Knowingly and intentionallydid not Follow the government SOPs of Social Distancing During sharing of bedroom and toilet with positive symptomatic case, used the same vehicle after it was used by the COVID-19 index case ,Spoke with Positive COVID-19 index case for more than 15mins few days before catching the disease, Individual did not use a face mask during all of his contact episodes with the positive index case, Participating in gathering or social events were all found to be poorly followed by the PCR positive contacts. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. e a s u r i n g o d d s o f v a r i o u s C O V I D -1 9 i n f e c t i o n p r e v e n t i o n & c o n t r o l m e a s u r e s a m o n g t h e c o n t a c t s t r a c e d d u r i n g t r a c e t e s t a n d q u a r a n t i n e a c t i v i t i e s a t d i s t r i c t Q u e t t a ( u n -m a t c h e d c a s e c o n t r o l s t u d y ) . A u t h o r s : M u h a m m a d A r i f , E h s a n L a r i k , A b i d S a e e d , M u h a m m a d A b d u l l a h . I n t r o d u c t i o n : T h e s e c o n d w a v e o f C O V I D -1 9 p a n d e m i c h a s s t a r t e d g l o b a l l y , r i g h t n o w g l o b a l l y 2 2 0 c o u n t r i e s a r e i n f e c t e d a n d a t o t a l o f 7 1 3 5 1 6 9 5 c o n f i r m e d c a s e s a n d 1 6 1 2 3 7 2 d e a t h s d u e t o C O V I D -1 9 h a s b e e n r e p o r t e d s o f a . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 30, 2021. T o a s s e s s t h e o d d s f o r c e r t a i n a n t i -C O V I D -1 9 I P C m e a s u r e s a m o n g t h e C o n t a c t s o f a n i n d e x C O V I D -1 9 c a s e t r a c e d b y P r o v i n c i a l D i s e a s e S u r v e i l l a n c e & R e s p o n s e u n i t Q u e t t a . • T o p r o v i d e e v i d e n c e b a s e d r e c o m m e n d a t i o n s f o r r i s k c o m m u n i c a t i o n t o t h e l o c a l c o n t e x t v i a m e d i a c e l l o f t h e H e a l t h d e p a r t m e n t o f B a l o c h i s t a n s o t h a t c e r t a i n C O V I D -1 9 I P C m e a s u r e s a r e a d o p . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 30, 2021. P D S R U Q u e t t a ' s F i e l d e p i d e m i o l o g i s t t e a m r e c o r d e d d e t a i l e d e p i d e m i o l o g i c a l r e p o r t s o f 6 0 0 C O V I D -1 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 30, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 30, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 30, 2021. T V I D -1 9 i n f e c t i o n p r e v e n t i o n a n d c o n t r o l ( I P C ) m e a s u r e s s t u d i e d a m o n g C O V I D -1 9 P C R p o s i t i v e c o n t a c t s ( c a s e s ) a n d C O V I D -1 9 P C R n e g a t i v e c o n t a c t s ( c o n t r o l s ) w e r e f o u n d t o b e s i g n i f i c a n t a s s h o w n b e l o w : T a b l e N o : 0 2 -O d d s r a t i o s f o r t h e v a r i o u s I n f e c t i o n p r e v e n t i o n a n d c o n t r o l m e a s u r e s s t u d i e d i . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted b e i n g a F a m i l y m e m b e r o f t h e i n d e x C O V I D -1 9 c a s e w a s 7 . 0 7 t i m e s m o r e a m o n g t h e P C R P o s i t i v e C o n t a c t s a s c o m p a r e t o t h e P C R n e g a t i v e C o n t a c t s ( p = 0 . 0 0 , C . I = 3 . 2 5 -1 5 . 8 6 ) , a l s o t h e o d d s f o r K n o w i n g l y a n d i n t e n t i o n a l l y r e c e i v e d a n o b j e c t h a n d e d o v e r b y a C O V I D -1 9 P o s i t i v e c a s e w a s 6 . 6 4 t i m e s m o r e a m o n g t h e P C R P o s i t i v e C o n t a c t s a s c o m p a r e t o P C R n e g a t i v e C o n t a c t . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 30, 2021. : T h e m a j o r f i n d i n g s o f t h i s s t u d y a r e a l m o s t i n l i n e w i t h t h e s e t h y p o t h e s i s , t h i s s t u d y i s c l e a r l y s h o w i n g t h a t t h e o d d s o f v a r i o u s C O V I D -1 9 i n f e c t i o n p r e v e n t i o n a n d c o n t r o l ( I P C ) m e a s u r e s s t u d i e d a m o n g C O V I D -1 9 P C R p o s i t i v e c o n t a c t s ( c a s e s ) a n d C O V I D -1 9 P C R n e g a t i v e c o n t a c t s ( c o n t r o l s ) w e r e f o u n d t o b e s i g n i f i c a n t l i k e w i s e t h e o d d s f o r K n o w i n g l y a n d i n t e n t i o n a l l y C o n t a c t e d w i t h a C O V I D -1 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 30, 2021. I ) a m o n g c o m m u n i t i e s a c c o r d i n g t h e i r c a l c u l a t i o n s W i t h o u t N P I s , t h e i r m o d e l p r e d i c t e d t h e n u m b e r o f c a s e s o f C O V I D -1 9 t o i n c r e a s e r a p i d l y a c r o s s C h i n a , w i t h a 5 1 -f o l d ( I Q R 3 3 -7 1 ) i n c r e a s e i n W u h a n , a 9 2 -f o l d ( 5 8 -1 3 3 ) i n c r e a s e i n o t h e r c i t i e s i n H u b e i p r o v i n c e a n d a 1 2 5 -f o l d ( 7 7 -1 8 0 ) i n c r e a s e i n o t h e r p r o v i n c e s b y 2 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 30, 2021. ; https://doi.org/10.1101/2021.07.25.21261084 doi: medRxiv preprint WHO. WHO coronavirus disease (COVID-19) dashboard. 2020 The effect of large-scale anti-contagion policies on the COVID-19 pandemic Effect of non-pharmaceutical interventions to contain COVID-19 in China Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility Spread of SARS-CoV-2 in the Icelandic population Epidemiology of Covid-19 in a long-term care facility in King County, Washington High SARS-CoV-2 attack rate following exposure at a choir practice Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study Connecting clusters of COVID-19: an epidemiological and serological investigation Epidemiological and clinical predictors of COVID-19 Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore COVID-19) advice for the public Presymptomatic transmission of SARS-CoV-2-Singapore International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity